|Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants|
F Posch, O Königsbrügge, C Zielinski, I Pabinger, C Ay
Thrombosis research 136 (3), 582-589, 2015
|A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts|
I Pabinger, N van Es, G Heinze, F Posch, J Riedl, EM Reitter, M Di Nisio, ...
The Lancet Haematology 5 (7), e289-e298, 2018
|Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism|
J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ...
Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017
|Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients|
LM Mauracher, F Posch, K Martinod, E Grilz, T Däullary, L Hell, C Brostjan, ...
Journal of Thrombosis and Haemostasis 16 (3), 508-518, 2018
|2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer|
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
|Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality|
C Ay, F Posch, A Kaider, C Zielinski, I Pabinger
Journal of Thrombosis and Haemostasis 13 (3), 390-397, 2015
|Single-stage revision for the infected total knee replacement: results from a single centre|
S Tibrewal, F Malagelada, L Jeyaseelan, F Posch, G Scott
The Bone & Joint Journal 96 (6), 759-764, 2014
|Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality|
J Riedl, F Posch, O Königsbrügge, F Lötsch, EM Reitter, E Eigenbauer, ...
PloS one 9 (10), e111440, 2014
|Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model|
F Posch, J Riedl, EM Reitter, A Kaider, C Zielinski, I Pabinger, C Ay
Thromb Haemost 115 (4), 817-826, 2016
|Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)|
J Gebhart, F Posch, S Koder, T Perkmann, P Quehenberger, C Zoghlami, ...
Blood, The Journal of the American Society of Hematology 125 (22), 3477-3483, 2015
|Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients|
O Königsbrügge, F Posch, J Riedl, EM Reitter, C Zielinski, I Pabinger, ...
The oncologist 21 (2), 252, 2016
|The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study|
MA Smolle, PU Tunn, E Goldenitsch, F Posch, J Szkandera, M Bergovec, ...
Annals of surgical oncology 24 (6), 1596-1605, 2017
|Prevalence of atrial fibrillation and antithrombotic therapy in hemodialysis patients: cross-sectional results of the Vienna InVestigation of AtriaL Fibrillation and …|
O Königsbrügge, F Posch, M Antlanger, J Kovarik, R Klauser-Braun, ...
PLoS One 12 (1), e0169400, 2017
|Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer|
F Posch, K Silina, S Leibl, A Mündlein, H Moch, A Siebenhüner, ...
Oncoimmunology 7 (2), e1378844, 2018
|Blood-based biomarkers are associated with disease recurrence and survival in gastrointestinal stroma tumor patients after surgical resection|
M Stotz, B Liegl-Atzwanger, F Posch, E Mrsic, M Thalhammer, ...
PloS one 11 (7), e0159448, 2016
|Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer|
E Grilz, O Königsbrügge, F Posch, M Schmidinger, R Pirker, IM Lang, ...
Haematologica 103 (9), 1549-1556, 2018
|MicroRNAs in different histologies of soft tissue sarcoma: a comprehensive review|
MA Smolle, A Leithner, F Posch, J Szkandera, B Liegl-Atzwanger, ...
International journal of molecular sciences 18 (9), 1960, 2017
|Soluble vascular endothelial growth factor (sVEGF) and the risk of venous thromboembolism in patients with cancer: results from the Vienna cancer and thrombosis study (CATS)|
F Posch, J Thaler, GJ Zlabinger, O Königsbrügge, S Koder, C Zielinski, ...
Clinical Cancer Research 22 (1), 200-206, 2016
|Risk stratification for venous thromboembolism in patients with testicular germ cell tumors|
A Bezan, F Posch, F Ploner, T Bauernhofer, M Pichler, J Szkandera, ...
PLoS One 12 (4), e0176283, 2017
|Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study|
F Lötsch, O Königsbrügge, F Posch, C Zielinski, I Pabinger, C Ay
Thrombosis research 134 (5), 1008-1013, 2014